Induction of HPV16 capsid protein-specific human T cell responses by virus-like particles

Biological Chemistry

Volumn 380, Issue 3, 1999, Pages 335-340

  Rudolf, Michael P ^a   Nieland, John D ^a   DaSilva, Diane M ^a,b   Velders, Markwin P ^a   Müller, Martin ^b   Greenstone, Heather L ^c   Schiller, John T ^c   Kast, W Martin ^a,b  

^a LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Cervical cancer; CTL; HLA A*0201; Human papilloma virus; Vaccine

Indexed keywords

CAPSID PROTEIN; CD8 ANTIGEN; CELL SURFACE RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PERFORIN; VIRUS CAPSID ANTIGEN; VIRUS VACCINE;

ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGENICITY; LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN PROCESSING; T LYMPHOCYTE; TARGET CELL; TUMOR CELL; UTERINE CERVIX CANCER; VACCINATION; VIRUS CAPSID; VIRUS INFECTIVITY; WART VIRUS;

HUMAN PAPILLOMA VIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; MIRIDAE; PAPILLOMAVIRUS;

EID: 0032970892     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.1999.045     Document Type: Article

References (22)

1. De Bruijn, M.L.H., Greenstone, H.L., Vermeulen, H., Melief, C.J.M., Lowy, D.R., Schiller, J.T., and Kast, W.M. (1998). L1 specific protection from tumor challenge elicited by HPV16 virus-like particles. Virology 250, 371-376.
2. Evander, M., Frazer, I.H., Payne, E., Qi, Y.M., Hengst, K., and McMillan, N.A. (1997). Identification of the alpha6 integrin as a candidate receptor for papillomaviruses. J. Virol. 71, 2449-2456.
3. Greenstone, H.L., Nieland, J.D., de Visser, K.E., De Bruijn, M.L., Kirnbauer, R., Roden, R.B., Lowy, D.R., Kast, W.M., and Schiller, J.T. (1998). Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model. Proc. Natl. Acad. Sci. USA 95, 1800-1805.
4. Kirnbauer, R., Booy, F., Cheng, N., Lowy, D.R., and Schiller, J.T. (1992). Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc. Natl. Acad. Sci. USA 89, 12180-12184.
5. Kirnbauer, R., Taub, J., Greenstone, H., Roden, R., Durst, M., Gissmann, L., Lowy, D.R., and Schiller, J.T. (1993). Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. J. Virol. 67, 6929-6936.
6. Maziarz, R.T., Burakoff, S.J., and Reiss, C.S. (1986). Viral-restricted cytolytic T lymphocyte recognition of hybrid human-murine class I histocompatibility antigens. Cell. Immunol. 99, 279-286.
7. Müller, M., Gissmann, L., Cristiano, R.J., Sun, X.Y, Frazer, I.H., Jenson, A.B., Alonso, A., Zentgraf, H., and Zhou, J. (1995). Papillomavirus capsid binding and uptake by cells from different tissues and species. J. Virol. 69, 948-954.
8. Müller, M., Zhou, J., Reed, T.D., Rittmuller, C., Burger, A., Gabelsberger, J., Braspenning, J., and Gissmann, L. (1997). Chimeric papillomavirus-like particles. Virology 234, 93-111.
9. Nimako, M., Fiander, A.N., Wilkinson, G.W., Borysiewicz, L.K., and Man, S. (1997). Human papillomavirus-specific cytotoxic T lymphocytes in patients with cervical intraepithelial neoplasia grade III. Cancer Res. 57, 4855-4861.
10. Peng, S., Frazer, I.H., Fernando, G.J., and Zhou, J. (1998). Papillomavirus virus-like particles can deliver defined CTL epitopes to the MHC class I pathway. Virology 240, 147-157.
11. Qi, Y.M., Peng, S.W., Hengst, K., Evander, M., Park, D.S., Zhou, J., and Frazer, I.H. (1996). Epithelial cells display separate receptors for papillomavirus VLPs and for soluble L1 capsid protein. Virology 276, 35-45.
12. Shepherd, P.S., Rowe, A.J., Cridland, J.C., Coletart, T., Wilson, P., and Luxton, J.C. (1996). Proliferative T cell responses to human papillomavirus type 16 L1 peptides in patients with cervical dysplasia. J. Gen. Virol. 77, 593-602.
13. Sonnenberg, A., Linders, C.J., Daams, J.H., and Kennel, S.J. (1990). The alpha 6 beta 1 (VLA-6) and alpha 6 beta 4 protein complexes: tissue distribution and biochemical properties. J. Cell Sci. 96, 207-221.
14. Stoler, M.H., Rhodes, C.R., Whitbeck, A., Wolinsky, S.M., Chow, L.T., and Broker, T.R. (1992). Human papillomavirus type 16 and 18 gene expression in cervical neoplasias. Hum. Pathol. 23, 117-128.
15. Taichman, L.B., and LaPorta, R.F. (1987). The expression of papillomaviruses in human epithelial cells. The Papovaviridae: Volume 2. The Papillomaviruses. N.P. Salzman, and P.M. Howley, eds. (New York: Plenum Press) pp. 109-139.
16. Touze, A., and Coursaget, P. (1998). In vitro gene transfer using human papillomavirus-like particles. Nucl. Acids Res. 26, 1317-1323.
17. Traversari, C., van der Bruggen, P., Van den Eynde, B., Hainaut, P., Lemoine, C., Ohta, N., Old, L., and Boon, T. (1992). Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes. Immunogenetics 35, 145-152.
18. Unckell, F., Streeck, R.E., and Sapp, M. (1997). Generation and neutralization of pseudovirions of human papillomavirus type 33. J. Virol. 71, 2934-2939.
19. Volpers, C., Unckell, F., Schirmacher, P., Streeck, R.E., and Sapp, M. (1995). Binding and internalization of human papillomavirus type 33 virus-like particles by eukaryotic cells. J. Virol. 69, 3258-3264.
20. Wadsworth, S., Halvorson, M.J., and Coligan, J.E. (1992). Developmentally regulated expression of the beta 4 integrin on immature mouse thymocytes. J. Immunol. 149, 421-428.
21. Zhou, J.A., McIndoe, A., Davies, H., Sun, X.Y., and Crawford, L. (1991). The induction of cytotoxic T-lymphocyte precursor cells by recombinant vaccinia virus expressing human papillomavirus type 16 L1. Virology 181, 203-210.
22. zur Hausen, H. (1991). Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 184, 9-13.